MiniMed Group, Inc. Common Stock (MMED) is a publicly traded the market company. As of May 21, 2026, MMED trades at $11.63 with a market cap of $3.06B and a P/E ratio of 0.00. MMED moved +6.98% today. Year to date, MMED is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $10.65 to $20.48. Analyst consensus is strong buy with an average price target of $20.85. Rallies surfaces MMED's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies organizes MMED SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
| Metric | Value |
|---|---|
| Price | $11.63 |
| Market Cap | $3.06B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $20.48 |
| 52-Week Low | $10.65 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
13 analysts cover MMED: 0 strong buy, 12 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $20.85.